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Stress perception, response, adaptation, and coping strategies are individually distinct,
and the sequel of stress and/or glucocorticoids (GCs) is also distinct between subjects. In
the last years, it has become clear that early life stress is a powerful modulator of neu-
roendocrine stress-responsive circuits, programing intrinsic susceptibility to stress, and
potentiating the appearance of stress-related disorders such as depression, anxiety, and
addiction. Herein we were interested in understanding how early life experiences reset the
normal processing of negative stimuli, leading to emotional dysfunction. Animals prenatally
exposed to GCs (in utero glucocorticoid exposure, iuGC) present hyperanxiety, increased
fear behavior, and hyper-reactivity to negative stimuli. In parallel, we found a remarkable
increase in the number of aversive 22 kHz ultrasonic vocalizations in response to an aversive
cue. Considering the suggested role of the mesopontine tegmentum cholinergic pathway,
arising from the laterodorsal tegmental nucleus (LDT) and pedunculopontine tegmental
nucleus (PPT), in the initiation of 22 kHz vocalizations and hypothetically in the control of
emotional arousal and tone, we decided to evaluate the condition of this circuit in iuGC
animals. Notably, in a basal situation, iuGC animals present increased choline acetyltrans-
ferase (ChAT) expression in the LDT and PPT, but not in other cholinergic nuclei, namely in
the nucleus basalis of Meynert. In addition, and in accordance with the amplified response
to an adverse stimulus of iuGC animals, we found marked changes in the cholinergic activa-
tion pattern of LDT and PPT regions. Altogether, our results suggest a specific cholinergic
pathway programing by prenatal GC, and hint that this may be of relevance in setting
individual stress vulnerability threshold.
Keywords: glucocorticoids, stress, acetylcholine, anxiety, fear, pedunculopontine tegmental nucleus, laterodorsal
tegmental nucleus, ultrasonic vocalizations
INTRODUCTION
Exposure to stressful events or synthetic glucocorticoids (GCs),
such as dexamethasone, early in life, are a risk factors for the
development of different neuropsychiatric disorders in adult-
hood, namely depression and anxiety (1). Such effects are par-
tially mediated by de-regulation of the hypothalamic-pituitary-
adrenal (HPA) axis, leading to altered GC secretion (2, 3), which
can induce long-term molecular and functional changes in GC-
sensitive nuclei. Importantly, several recent studies showed that
high levels of GCs have a deleterious effect in the developing
brain, inducing prominent neurochemical, structural, and mol-
ecular changes in several brain regions (4–8) culminating in the
development of anxious and depressive-like traits (9–13).
GC programing effects in emotional behavior are far from
being completely understood at a mechanistic level, but it has
been shown that GCs modulate on the long-term the activity
of particular neural pathways. In this perspective it is interest-
ing to refer that early life stress/GC exert a powerful effect in
the developing dopaminergic neurons, especially at the mesolim-
bic level (7). For example, we have shown that animals prena-
tally exposed to GC present marked hypodopaminergia and D2
epigenetic/expression changes, responsible for their anhedonia
and motivational deficits, since administration of a dopamine
precursor, l-DOPA, fully reverted the molecular and behavioral
impairments (14, 15). Obviously, this dopaminergic de-regulation
may also occur indirectly through modulation of upstream neu-
rotransmitter systems. One promising candidate is the ascending
cholinergic pathway, comprising projections from acetylcholine
(ACh)-rich nuclei within the pons, particularly the laterodorsal
(LDT) and pedunculopontine tegmental nuclei (PPT) to the ven-
tral tegmental area (VTA) (16–18). In support of this, it was
already shown that stress/GC strongly elicit cholinergic activity
of these regions (19), and that they, in turn, critically affect basal
and phasic activity of VTA neurons (20–23). Additionally, GC can
putatively bind to GC-responsive elements of cholinergic play-
ers and control their expression, namely choline acetyltransferase
(ChAT) (24) and acetylcholine esterase (AChE) (25), two enzymes
of the cholinergic pathway. Also relevant is to note that the ascend-
ing cholinergic system is implicated in the control of the stress
response by modulating hypothalamic pituitary adrenal (HPA)
axis function (26–28) and in mediating the anxiogenic effects of
stress (29–31).
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Surprisingly, very few studies have focused on the impact of
stress/GC exposure in the cholinergic system. Considering the lack
of evidence, herein, we focused on the impact of prenatal exposure
to GCs in the ascending cholinergic system, and the relevance of
such changes in stress-related anxious and fear behaviors.
MATERIALS AND METHODS
ANIMALS AND TREATMENTS
All manipulations were conducted in accordance with local reg-
ulations on animal care and experimentation (European Union
Directive 2010/63/EU). Pregnant Wistar Han rats were sub-
cutaneously injected with the synthetic GC dexamethasone at
1 mg kg−1 (in utero glucocorticoid exposure, iuGC animals), or
with vehicle (CONT; control animals), on days 18 and 19 of
gestation.
Dexamethasone dosage was selected based on our previous
studies showing that this regimen effectively impairs HPA axis
activity in a long-term basis (12). From a clinical perspective,
guidelines on prenatal corticotherapy (32, 33) recommend single
course administration (0.3–0.5 mg/kg), however, multiple courses
of GCs are often administered (34), despite the lack of evidence of
increased therapeutic efficacy. Nevertheless, we must consider the
difficulty in the transposition of human doses to rodents due to
ADME species specificity.
At weaning day, male offspring were house-paired ran-
domly, according with prenatal treatment, under standard lab-
oratory conditions: artificial 12 h light/dark cycle (lights on
from 08:00 a.m. to 08:00 p.m.); room temperature 22°C; food
and water were provided ad libitum. Animals derived from at
least three different litters were used for all the experimental
procedures.
BEHAVIORAL TESTS
All tests were performed during the day period, except the con-
fined cage and fear-conditioning protocols that were conducted
during the night period (08:30 p.m. to 03:00 a.m.). All behavioral
equipment was cleaned between animals (ethanol 10%) in order
to remove any olfactory cues.
OPEN FIELD
The open field (OF) test was conducted in an arena
(43.2 cm× 43.2 cm) with transparent acrylic walls and white floor
(Med Associates Inc., St. Albans, VT, USA). Rats were placed in
the center of the arena and movement was monitored over a
period of 10 min with the aid of two 16-beam infrared arrays.
Total distance traveled was used as an indicator of locomotor
activity.
ELEVATED PLUS MAZE
The elevated plus maze (EPM) test was carried out under
bright white light. Animals were placed individually for 5 min
in the center of a black polypropylene plus-shaped platform
elevated 72.4 cm above the floor. The apparatus consisted
of two open arms (50.8 cm× 10.2 cm) and two closed arms
(50.8 cm× 10.2 cm× 40.6 cm) (MedAssociates Inc., St. Albans,
VT, USA). The number of entries into each arm and the time
spent therein were recorded.
LIGHT/DARK BOX TEST
The light/dark box (L/D) test was performed inside the OF arena
(43.2 cm× 43.2 cm) (MedAssociates Inc., St. Albans, VT, USA).
A dark compartment was attached to one side with an opening
facing the center of the arena. Animals were individually placed
in the center of the illuminated part. The distance traveled and
time spent in each compartment was recorded in a single trial of
10 min.
CONFINED CAGE TEST
The confined cage test was performed in a non-restrictive Plexi-
glas cylinder (inner diameter 8.8 cm, length 22.2 cm), mounted on
a Plexiglas platform and placed in a ventilated, sound-attenuated
chamber (SR-LAB, San Diego Instruments, San Diego, CA, USA).
A stainless steel grid was placed inside the cylinder, through which
an electric current could be passed (shock chamber). A micro-
phone and a video camera were placed inside the sound-attenuated
chamber. The protocol was performed in two consecutive days,
in which the animals were placed inside the shock chamber for
3 min. The ultrasonic vocalizations (USVs) and the percentage of
total freezing time were measured.
FEAR-CONDITIONING PARADIGM
The fear-conditioning test was performed in a non-restrictive Plex-
iglas cylinder (inner diameter 8.8 cm, length 22.2 cm), mounted on
a Plexiglas platform and placed in a ventilated, sound-attenuated
chamber (SR-LAB, San Diego Instruments, San Diego, CA, USA).
The protocol was performed in three consecutive days (35). On
the first day (habituation), each animal was placed in the shock
chamber for 11 min. On the second day (conditioning), each sub-
ject was positioned inside the shock chamber for 3 min (no light,
no shock). Afterwards, animals were exposed to six lights/shock
pairings (0.4± 0.1 mA), with an inter-stimulus-interval (ISI) of
60 s. The shock was given for 500 ms, immediately after the cue
light was turned off. On the following day (test day), after an ini-
tial phase of 3 min without light, animals were presented with
a 20 s cue light for six times, but no shock was given (ISI of
60 s). During all procedures, USVs and freezing behavior were
recorded.
USVs ANALYSIS
An ultrasound microphone (CM16/CMPA, Avisoft Bioacoustics,
Berlin, Germany) sensitive to frequencies of 10–200 kHz, placed
15 cm above the floor, was used in all experiments. The micro-
phone was connected via an Avisoft UltrasoundGate 416H (Avisoft
Bioacoustics) to a personal computer; USVs were recorded using
the Avisoft-Recorder (version 5.1.04) with the following settings:
sampling rate: 250,000; format: 16 bit. For acoustical analysis,
recordings were transferred to Avisoft SASLab Pro (version 5.1.22,
Avisoft Bioacoustics). This program was used in order to produce
spectrograms of USVs by conducting a fast Fourier transformation
(256 FFT-length, 100% frame, Hamming window filter, 50% time
window overlap). These spectrograms had a frequency resolution
∼1.2 kHz and a temporal resolution∼0.4 ms.
Twenty-two kilohertz call detection was provided by an auto-
mated threshold-based algorithm (threshold:−40 dB) and a hold
time mechanism (hold time: 20 ms). A lower-cut-off-frequency of
18 kHz was used to reduce background noise.
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Calls were also inspected manually to ensure that, when nec-
essary, USVs not detected automatically could be subsequently
included in the automatic parameter analysis.
IMMUNOHISTOCHEMISTRY
For immunohistochemistry (IHC), 11 rats were sacrificed by pen-
tobarbital (Eutasil, Sanofi) anesthesia and transcardially perfused
with 0.9% saline followed by 4% paraformaldehyde (pH 7.4 in
0.1 M phosphate buffer). Brains were removed and post-fixed for
48 h in 4% paraformaldehyde and then rinsed and stored in 30%
of sucrose until sectioning. Brains were sectioned coronally, at a
thickness of 50µm, on a vibratome (VT1000S, Leica, Germany)
and stored in cryoprotectant solution at−20°C until use.
Briefly, free-floating sections were pre-treated with 3% H2O2
in PBS, thoroughly rinsed in PBS, blocked with 2.5% fetal bovine
serum (FBS) in PBS-Triton 0.3% for 2 h at room tempera-
ture, and then incubated overnight at 4°C with primary anti-
body goat anti-ChAT (Millipore, MA, USA; 1:1000). Afterwards,
sections were washed, incubated with the secondary biotiny-
lated anti-goat (Vector Lab., USA; 1:200) for 1 h, and processed
with an avidin-biotin complex solution (ABC-Elite Vectastain
reagent; Vector Lab, USA). Detection was done using 0.5 mg/ml
3,3′-diaminobenzidine. Sections were washed and mounted on
glass slides, air-dried, counterstained with hematoxylin, and cover
slipped with Entellan-New (Merck, Darmstadt, Germany).
IMMUNOFLUORESCENCE
Ninety minutes after completion of the fear-conditioning par-
adigm, 12 animals were deeply anesthetized with pentobarbital
(Eutasil, Sanofi) and were transcardially perfused with 0.9% saline
followed by 4% paraformaldehyde. Brains were removed and
post-fixed in 4% paraformaldehyde. Coronal vibratome sections
(50µm) were first incubated with rabbit anti-c-fos primary anti-
body (1:1000; Ab-5, Calbiochem, USA), followed by incuba-
tion with goat anti-ChAT primary antibody (1:1000; anti-ChAT,
Millipore, MA, USA). Secondary fluorescent antibodies were:
Dylight 488-conjugated donkey anti-rabbit IgG (1:500, BioLe-
gend), and Alexa Fluor 568-conjugated donkey anti-goat IgG
(1:500, Invitrogen), respectively. Finally, all sections were stained
with 4′,6-diamidino-2-phenylindole (DAPI; 1 mg/ml). For each
animal, c-fos-positive cells within the PPT and LDT were ana-
lyzed after double staining with cholinergic (ChAT) marker and
cell counts were performed by confocal microscopy (Olympus
FluoViewTMFV1000, Hamburg, Germany). Estimation of cell
density was obtained by crossing cell number values with the
corresponding areas, determined using an Olympus BX51 optical
microscope and the StereoInvestigator software (Microbrightfield,
VT, USA).
STEREOLOGICAL PROCEDURES
Eleven animals were perfused transcardially with 4% paraformalde-
hyde, under deep pentobarbital (Eutasil, Sanofi) anesthesia. Brains
were included in glycolmethacrylate (Tecnovit 7100, Heraeus
Kulzer, Wehrheim, Germany) and sectioned on a microtome as
described in detail elsewhere (36). Every other 30µm thick coronal
section was collected on a gelatinized slide, stained with Giemsa,
mounted with Entellan-New (Merck, Darmstadt, Germany), and
cover slipped. Stereological procedures were performed by a blind
observer.
Laterodorsal tegmental and PPT regions were outlined accord-
ing to the atlas of Paxinos and Watson (37) and based on noticeable
cytoarchitectural differences, namely density of cells and size of the
perikarya.
Volume and neuronal number estimations were performed
using StereoInvestigator software (Microbrightfield,VT, USA) and
a camera attached to a motorized microscope (Axioplan 2, Carl
Zeiss, Germany). The Cavalieri’s principle was used to assess vol-
ume. Briefly, every second section was used and the cross-sectional
area was estimated by point counting (final magnification 112×).
We used a test point system in which the interpoint distance, at
the tissue level, was 150µm for LDT and 200µm for PPT. The
volume of the region of interest was calculated from the number
of points within its boundaries and the distance between sampled
sections.
Average cell numbers were estimated using the optical frac-
tionator method (38). Briefly, a grid of virtual 3D-boxes
(LDT: 30µm× 30µm× 20µm; PPT: 40µm× 40µm× 20µm)
equally spaced (using the same grid spacing as for volume estima-
tions) was superimposed on every second section of the lamina of
interest and cells within boxes were counted. Coefficients of error
(CE) were automatically computed, according to the formulas of
Gundersen et al. (39) for cell numbers and Gundersen et al. (40)
for volume estimations. Glial cells were not included in the esti-
mations, and the discrimination between neuronal and glial cell
body profiles was based on the criteria described by Ling et al. (41)
and Peinado et al. (42).
STATISTICAL ANALYSIS
Statistical analysis was performed in GraphPad Prism 5.0 (Graph-
Pad Software, Inc., La Jolla, CA, USA). Statistical analysis between
two groups was made using Student’s t -test or Mann–Whitney
tests. Two-way analysis of variance (ANOVA) was used when
appropriate. Bonferroni’s post hoc multiple comparison test was
used for group differences determination. Non-parametric analy-
sis (Mann–Whitney test) was used when normality of data was
not assumed. Results are presented as mean± SEM. Statistical
significance was accepted for p≤ 0.05.
RESULTS
IN UTERO GLUCOCORTICOID EXPOSURE IMPAIRS EMOTIONAL
BEHAVIOR
Animals were exposed to a battery of behavioral tests that con-
sisted of paradigms studying spontaneous exploratory behavior
(OF), tasks of innate anxiety (EPM, L/D test, confined cage), and
reactivity to adverse stimulus (version of fear-conditioning para-
digm). Since USVs can give information on the emotional status
of the animal, we decided to further complement the behavioral
characterization by measuring USVs in these different paradigms.
In the OF, iuGC animals presented a decrease in the number
of ambulatory counts (Figure 1A, t = 2.197, p= 0.037) and total
distance traveled (Figure 1B, t = 3.002, p= 0.006) when com-
pared with control animals. In addition, iuGC animals exhibited a
decrease in the percentage of time spent in the center of the arena
(Figure 1C, t = 2.416, p= 0.023).
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FIGURE 1 | In utero glucocorticoid exposure induces an anxious-like
behavior. iuGC group presented a decrease in ambulatory counts (A),
total distance traveled (B), and percentage of time in the center of the
arena (C). In the EPM, iuGC animals exhibited a decrease in the
percentage of time spent (D) and number of entries (E) in the open arms
of the maze, when compared with control group. (F) In the L/D test, iuGC
presented an increase in the ratio dark/light, with no differences on the
distance traveled in both compartments (G). In the confined cage, iuGC
group presented an increase in the number of 22 kHz USVs (H) and
freezing behavior (I). Upon habituation, iuGC animals no longer presented
this anxious behavior (day 2). CONT, control animals; iuGC, in utero GC
exposed animals; USVs, ultrasonic vocalizations. *p<0.05, **p<0.001,
and ***p<0.0001; (A–C) n=16; (D,E) n=11–13; (F,G) n=10, (H,I)
n=8–16.
In the EPM, iuGC animals spent significantly less time in
the open arms (Figure 1D, t = 2.947, p= 0.009) and presented
a reduction in the number of open arms entries (Figure 1E,
t = 2.375, p= 0.031), when compared with control animals. No
differences were found in the time and entries in the closed arms
(data not shown; time: t = 0.479, p= 0.637; entries: t = 0.872,
p= 0.392).
In the L/D test, iuGC animals presented an increase in the
ratio dark/light (Figure 1F, t = 2.765, p= 0.014) and no differ-
ences in distance traveled in both compartments (Figure 1G, dark:
t = 0.117, p= 0.909; light: t = 0.137, p= 0.893).
In the confined cage, while control animals rarely emit-
ted aversive 22 kHz USVs, iuGC animals vocalized throughout
the exposure (Figure 1H; U = 81, p= 0.016). Similarly, iuGC
group presented increased freezing behavior (Figure 1I; t = 2.846,
p= 0.013). Upon habituation to the cage (2 days of exposure),
iuGC animals no longer presented this anxious-like response.
To investigate reactivity to an adverse stimulus, we performed
a variation of the classical fear-conditioning paradigm. Animals
were conditioned to a cue (light) predicting painful electric shocks.
After cage habituation, animals were given six pairs of cue-shock.
No emission of 22 kHz USVs was observed in the baseline phase
(0–3 min), but upon light/shock pairings, as expected, both groups
significantly emitted more negative USVs. iuGC animals emitted
negative USVs to a greater extent than control animals (Figure 2A,
t = 1.562, p= 0.130) and also presented an increase in freezing
behavior time (Figure 2B, t = 2.355, p= 0.034). After this condi-
tioning session, in the next day, animals were exposed to the cue,
but no shock was given. In the initial period, both groups emitted
more 22 kHz USVs than the day before (F1,58= 4.10, p= 0.047);
cue exposure elicited more negative USVs in both groups, but
again, iuGC animals were over-reactive (Figure 2C, t = 2.804,
p= 0.011). Analysis of freezing behavior further confirmed the
phenotype of iuGC group (Figure 2D, t = 2.087, p= 0.049). Plot-
ting the number of negative USVs along time further confirms
that iuGC animals were over-reactive to the cue predicting the
adverse stimulus, since iuGC group emitted more context-induced
22 kHz vocalizations than control group, especially in the first 60 s
(Figure 2E, F1,131= 104.42, p< 0.0001). Upon the first cue expo-
sure (ON period), both groups increased the number of USVs
with no major differences between them. However, upon second
cue exposure, iuGC animals emitted more negative USVs than
control group and remained over-reactive throughout. The pat-
tern of 22 kHz USVs emission in both groups is interesting since
immediately after the light is turned off, both groups emit more
negative vocalizations, indicative of the consolidated association
of the cue with the electric shock.
iuGC EXPOSURE INDUCES PROMINENT CHOLINERGIC ALTERATIONS
Pharmacological studies suggest that the ascending cholinergic
tegmental system is responsible for the initiation and produc-
tion of negative vocalizations in rodents (43–45). In addition,
cholinergic signaling is highly responsive to stress/GC (46) and
is important for the manifestation of aversive behaviors (47).
Considering these findings, we decided to further explore the
impact of iuGC exposure in the cholinergic circuitry. To do so,
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FIGURE 2 | Prenatal exposure to GC leads to amplified response to
adverse stimulus. (A) Number of 22 kHz USVs on the conditioning day
(cue+ shock) of the fear-conditioning paradigm. iuGC group emitted more
negative calls than control animals in the light/shock period. (B) Similarly,
iuGC group displayed increased percentage of freezing behavior in
comparison with control animals. On the test day, animals were exposed
six times to cue but no shock was given. iuGC presented an increase in
the number of USVs (C) and in freezing time (D). (E) iuGC animals are
hyper-reactive throughout time, since they emit more context-induced
22 kHz vocalizations than control group, especially in the first 60 s. Upon
first cue exposure (ON period), both groups increased the number of USVs
with no major differences between them. However, upon second cue
exposure, iuGC animals emitted more negative USVs than controls and
remained over-reactive during time. CONT, control animals; iuGC, in utero
GC exposed animals; USVs, ultrasonic vocalizations. *p<0.05,
**p<0.001, ***p<0.0001, δ: trend, p=0.130; (A–E) n=8–16.
we have performed IHC against ChAT, the key enzyme in ACh
synthesis. The number of ChAT-positive cells in the LDT was
significantly higher in iuGC animals when compared to control
group (Figures 3A,B; 49% increase; U = 3, p= 0.026). The PPT,
a LDT adjacent region, also presented substantial increase in the
number of ChAT-positive cells (Figures 3C,D; U = 2, p= 0.024).
On the contrary, the nucleus basalis of Meynert did not show
any significant alteration in the number of cholinergic positive
cells (Figures 3E,F; U = 8, p= 0.315). Other regions such as the
NAc (core and shell), rich in cholinergic interneurons, also did
not show any differences in the number of ChAT-positive cells
(Figures 3G,H; core: U = 13, p= 0.927; shell: U = 6, p= 0.164).
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FIGURE 3 | Mesopontine cholinergic de-regulation in iuGC
animals. (A) LDT ChAT immunohistochemistry revealed that iuGC
animals presented increased ChAT expression (B). (C,D) Similarly,
iuGC animals present increased ChAT staining in the PPT region.
Conversely, no differences were found in ChAT expression in the
nucleus basalis of Meynert (E,F) or in the nucleus accumbens core or
shell (G,H). Representative images of coronal brain sections; numbers
represent distance in mm posterior to bregma. CONT, control animals;
iuGC, in utero GC exposed animals; LDT, laterodorsal tegmental
nucleus; NAc, nucleus accumbens; PPT, pedunculopontine tegmental
nucleus. *p<0.05, **p<0.001, ***p<0.0001; (A) n=4–7. Scale
bars: 50µm.
Because iuGC can induce relevant structural changes, we mea-
sured the volume and number of cells in the LDT and PPT
nuclei. No statistical differences regarding the volume of LDT were
found between control and iuGC animals (Figures 4A–C; volume:
U = 5, p= 0.486; cell numbers: U = 3, p= 0.200). In the PPT, no
significant differences in volume and cell numbers were found
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FIGURE 4 | Stereological data of LDT and PPT regions. No major
differences were observed in the volumes and cell numbers of LDT
(A–C) and PPT regions (D–F) of iuGC animals when compared to
controls. Representative images of coronal brain sections; numbers
represent distance in millimeters posterior to bregma. CONT, control
animals; iuGC, in utero GC exposed animals; LDT, laterodorsal tegmental
nucleus; PPT, pedunculopontine tegmental nucleus. (B,C) n=5–6;
(E,F) n=4.
(Figures 4D–F; volume: U = 2, p= 0.114; cell numbers: U = 2,
p= 0.229).
To assess if the observed increase in ChAT-positive cells in iuGC
group was translated into augmented ACh release, we measured
the levels of ACh in cholinoceptive regions. A trend for increased
ACh levels in the hypothalamus and the amygdala was found (data
not shown).
CHOLINERGIC NEURONS IN THE LDT AND PPT ARE DIFFERENTIALLY
ACTIVATED UPON ADVERSE STIMULUS IN iuGC ANIMALS
To better determine the impact of iuGC in cholinergic neu-
rons, and the relevance of such changes in reaction to adverse
stimuli, we evaluated neuronal activation patterns using c-fos
labeling in combination with ChAT after the fear-conditioning
protocol.
Briefly, animals were subjected to the modified fear-
conditioning protocol, and sacrificed 90 min after stimuli on the
test day. As depicted in Figure 5, after an adverse stimulus, iuGC
animals presented a significant increase (85%) in the number of
c-fos-positive cells in the LDT (Figures 5A,B; U = 0, p= 0.008).
The number of ChAT-positive cells was also substantially aug-
mented (64%) in iuGC animals when compared to control animals
(Figure 5C; U = 0, p= 0.014).
Regarding the PPT, after the adverse stimuli, iuGC animals
present 2.5 times more c-fos-positive cells than control animals
(Figures 5E,F; U = 0, p= 0.002). Similarly, the number of ChAT-
positive cells was also increased in iuGC animals (Figure 5G;
U = 0, p= 0.002).
To determine if the observed increase in c-fos-positive cells
was due to enhanced cholinergic activation, we also quantified
the number of c-fos/ChAT-positive cells after fear conditioning.
Remarkably, iuGC animals presented a substantial increase
(186%) in the number of c-fos/ChAT-positive cells in the LDT
in comparison to control animals (Figure 5D; U = 4, p= 0.029).
Similarly, in the PPT, we observed that iuGC animals display a
four-time increase in the number of double c-fos/ChAT-positive
cells (Figure 5H; 3.358 vs. 0.801%, U = 4.5, p= 0.030).
DISCUSSION
Confirming previous findings (12, 14, 48), we observed that iuGC
animals present an anxious phenotype. In the EPM, iuGC ani-
mals presented a decrease in the time and entries in the open
arms when compared with control animals, in accordance with
the L/D test, where they spent less time in the anxiogenic com-
partment. Moreover, iuGC animals emitted more 22 kHz negative
calls and presented enhanced freezing behavior in the confined
cage paradigm. These differences were eliminated by habituation.
This is in accordance with previous work showing that rats that
are highly anxious tend to vocalize more often and present aug-
mented freezing time during aversive stimuli than rats that display
low anxiety-like trait (35). In the fear-conditioning paradigm,
iuGC animals emitted more negative calls and enhanced freezing
behavior on the conditioning day. This suggests an emotional over-
reactivity of iuGC animals to adverse stimulus. In further support
of this idea, iuGC animals emitted more negative calls than control
subjects in response to the cue predicting the harmful stimulus and
during ISI, suggesting an over-reactive response. Altogether, our
data confirms that iuGC exposure leads to anxious behavior and
exacerbated response to stressful events in adulthood, a finding
also observed in other stress models (49–51). Similarly, a rat line
that displays signs of extreme trait anxiety also presents increased
stress vulnerability and reactivity (52).
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FIGURE 5 | Differential cholinergic activation of the LDT and PPT regions
in iuGC animals after an adverse stimulus. (A) Representative images of
LDT ChAT (red labeling) and c-fos (green labeling) immunostaining in animals
exposed to the fear-conditioning test. (B) Increased c-fos activation in iuGC
animals. (C) ChAT expression was increased in iuGC animals in comparison to
controls. (D) The number of c-fos/ChAT-positive cells was substantially
increased in the LDT of iuGC animals. (E) Representative images of PPT
ChAT and c-fos immunostaining in animals exposed to the fear-conditioning
test. (F) Increased c-fos staining in iuGC animals. (G) ChAT expression was
augmented in iuGC animals. (H) The number of c-fos/ChAT-positive cells is
significantly increased in the PPT of iuGC group. CONT, control animals; iuGC,
in utero GC exposed animals; LDT, laterodorsal tegmental nucleus; PPT,
pedunculopontine tegmental nucleus. *p<0.05, **p<0.001; (A–H) n=6.
Scale bars: 50µm.
One remarkable finding was the increased emission of negative
calls in iuGC animals, hinting differential activity of the meso-
pontine cholinergic circuitry, that mainly comprises projections
from the LDT region (43, 44, 53, 54). In accordance, we found
increased ChAT expression in the LDT of iuGC animals in a basal
situation, suggesting overproduction of ACh. Upon exposure to a
cue predicting an adverse stimulus, there was a marked increase
in the number of c-fos/ChAT-positive cells, potentially explain-
ing iuGC behavioral response. Indeed it was shown that LDT
activation induces a complex state of defensiveness, critical for
alarm responses to dangerous stimuli (44, 45). Our results are in
accordance with previous work, in which they have shown that
pharmacological stimulation of the LDT lead to an increase in the
emission of 22 kHz USVs (44). In addition, the increased LDT
cholinergic signaling could also be implicated in the impaired
negative HPA axis feedback of iuGC animals (12) since LDT-
arising ACh enhances ACTH and CRF release (28, 55, 56). On
the other hand, GC also modulate cholinergic signaling (19), sug-
gesting a reciprocal ACh-GC control that may culminate in a
vicious loop.
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Alike the LDT, iuGC animals presented increased PPT cholin-
ergic signaling both in a basal situation and after exposure to the
cue predicting an adverse stimulus. Apart from the classical role
of PPT in sleep and arousal, lesion studies suggest a role in anx-
iety modulation, although both anxiogenic and anxiolytic effects
were found depending on the degree and type of lesion. Excito-
toxic and electrolytic PPT lesions induce an anxiogenic-like status
(57, 58), contrary to one study that suggests a slight anxiolytic
effect (59). On the other hand, ibotenic lesions seem to reduce
anxious-like phenotype (60). Apart from distinct technical proce-
dures, it has been suggested that opposing results may arise from
damage in different sub-regions within the PPT (pars compacta
vs. dissipata) or in surrounding regions, namely the cuneiform
nucleus (59, 61).
This programing effect of iuGC exposure is not so surpris-
ing considering the importance of GC receptors for the matura-
tion of medial septal and hippocampal cholinergic neurons (62,
63), yet, more studies need to be performed to understand how
GC exert long-lasting functional and molecular changes in these
neurons.
In utero glucocorticoid exposure-induced alterations in the
mesopontine cholinergic pathway may go beyond a direct effect
of cholinergic inputs on behavioral output. For instance, LDT-
dependent cholinergic activation of VTA evokes dopamine release
in the NAc (20, 21, 64) driving motivational and reward behaviors
(65, 66). However, these findings are somewhat contradictory to
the VTA-accumbal hypodopaminergia and anhedonia observed in
iuGC animals (6, 14, 15). One possible explanation is that the sus-
tained augmented LDT-VTA ACh signaling could desensitize or
alter the expression/epigenetic status of the nicotinic/muscarinic
receptors as a compensatory mechanism. Indeed, GC or acute
stress can induce prominent ACh release in specific brain regions
(46, 67, 68), and transiently change the expression levels of differ-
ent cholinergic players through c-fos binding to promoter regions
of target genes in order to maintain the homeostasis (19). Addi-
tional studies focusing on the regulation of the expression of differ-
ent cholinergic players by GC will be critical to better comprehend
our findings.
In summary, our results show for the first time that prenatal GC
exposure programs the mesopontine cholinergic pathway, leading
to cholinergic hyperactivation of both the LDT and PPT, which
in turn can underlie the anxious behavior and enhanced stress
reactivity observed in these animals.
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